CIPHER Trademark

Trademark Overview

On Wednesday, April 1, 2020, a trademark application was filed for CIPHER with the United States Patent and Trademark Office. The USPTO has given the CIPHER trademark a serial number of 88856318. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 16, 2024. This trademark is owned by Repertoire Immune Medicines, Inc.. The CIPHER trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Diagnostic kits comprised of diagnostic reagents and assay components for clinical and medical laboratory use; medical diagnostic reagents and assay components for testing of body fluids including blood and plasma, and cells

Pharmaceutical research, medical research; custom development of biochemical reagents and assays; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; all of the foregoing relating to immunology and none of the foregoing relating to genomic sequencing from blood samples

General Information

Serial Number88856318
Word MarkCIPHER
Filing DateWednesday, April 1, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements

Goods and ServicesDiagnostic kits comprised of diagnostic reagents and assay components for clinical and medical laboratory use; medical diagnostic reagents and assay components for testing of body fluids including blood and plasma, and cells
Goods and ServicesPharmaceutical research, medical research; custom development of biochemical reagents and assays; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; all of the foregoing relating to immunology and none of the foregoing relating to genomic sequencing from blood samples

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 1, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 1, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRepertoire Immune Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRepertoire Immune Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Wednesday, April 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 22, 2020ASSIGNED TO EXAMINER
Sunday, June 28, 2020NON-FINAL ACTION WRITTEN
Sunday, June 28, 2020NON-FINAL ACTION E-MAILED
Sunday, June 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 1, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 1, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 22, 2020NON-FINAL ACTION WRITTEN
Thursday, October 22, 2020NON-FINAL ACTION E-MAILED
Thursday, October 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 21, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 10, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 7, 2022SOU TEAS EXTENSION RECEIVED
Monday, February 7, 2022SOU EXTENSION 1 FILED
Monday, February 7, 2022SOU EXTENSION 1 GRANTED
Wednesday, February 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 4, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 4, 2022SOU EXTENSION 2 FILED
Thursday, August 4, 2022SOU EXTENSION 2 GRANTED
Saturday, August 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 7, 2023SOU EXTENSION 3 FILED
Tuesday, February 7, 2023SOU EXTENSION 3 GRANTED
Thursday, February 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023SOU EXTENSION 4 FILED
Thursday, August 3, 2023SOU EXTENSION 4 GRANTED
Saturday, August 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 6, 2024SOU EXTENSION 5 FILED
Wednesday, February 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 21, 2024SOU EXTENSION 5 GRANTED
Thursday, February 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

cipher medical diagnostic reagents development foregoing research blood relating components assay